Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma

Schilling, B.; Sondermann, W.; Zhao, F.; Griewank, K. G.; Livingstone, E.; Sucker, A.; Zelba, H.; Weide, B.; Trefzer, U.; Wilhelm, T.; Loquai, C.; Berking, C.; Hassel, J.; Kahler, K. C.; Utikal, J.; Al Ghazal, P.; Gutzmer, R.; Goldinger, S. M.; Zimmer, L.; Paschen, A.; Hillen, U.; Schadendorf, D.

dc.contributor.author	Zelba, Henning
dc.contributor.author	Weide, Benjamin Matthias
dc.date.accessioned	2014-08-19T11:34:22Z
dc.date.available	2014-08-19T11:34:22Z
dc.date.issued	2014
dc.identifier.issn	0923-7534
dc.identifier.uri	http://hdl.handle.net/10900/55508
dc.language.iso	en	en
dc.publisher	Oxford Univ Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1093/annonc/mdt587	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140610213910_00590	de_DE
utue.publikation.seiten	747-753	de_DE
utue.personen.roh	Schilling, B.
utue.personen.roh	Sondermann, W.
utue.personen.roh	Zhao, F.
utue.personen.roh	Griewank, K. G.
utue.personen.roh	Livingstone, E.
utue.personen.roh	Sucker, A.
utue.personen.roh	Zelba, H.
utue.personen.roh	Weide, B.
utue.personen.roh	Trefzer, U.
utue.personen.roh	Wilhelm, T.
utue.personen.roh	Loquai, C.
utue.personen.roh	Berking, C.
utue.personen.roh	Hassel, J.
utue.personen.roh	Kahler, K. C.
utue.personen.roh	Utikal, J.
utue.personen.roh	Al Ghazal, P.
utue.personen.roh	Gutzmer, R.
utue.personen.roh	Goldinger, S. M.
utue.personen.roh	Zimmer, L.
utue.personen.roh	Paschen, A.
utue.personen.roh	Hillen, U.
utue.personen.roh	Schadendorf, D.
dcterms.isPartOf.ZSTitelID	Annals of Oncology	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	25	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE